Application 204033
- Type
- ANDA
- Sponsor
- LANNETT CO INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MEMANTINE HYDROCHLORIDE | MEMANTINE HYDROCHLORIDE | SOLUTION;ORAL | 2MG/ML | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204033-001 | MEMANTINE HYDROCHLORIDE | MEMANTINE HYDROCHLORIDE | 2MG/ML | SOLUTION / ORAL | AA | RS | 2015-10-13 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A204033-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A204033-001 | MEMANTINE HYDROCHLORIDE | 2MG/ML | SOLUTION / ORAL | AA | RS | 2015-10-13 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A204033-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Memantine Hydrochloride | MEMANTINE HYDROCHLORIDE | Chartwell Governmental & Specialty RX, LLC. | d1f97615-e888-421e-b50a-95a87a1965ff | 2026-02-06 | Warnings, Adverse reactions | 204033 ANDA204033 |
| Memantine Hydrochloride | MEMANTINE HYDROCHLORIDE | Chartwell RX, LLC | a7b76864-6de7-45f6-be5b-5ecfca811627 | 2026-01-30 | Warnings, Adverse reactions | 204033 ANDA204033 62135-943 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0121-0850 | Memantine Hydrochloride | Memantine Hydrochloride | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0850 | Memantine Hydrochloride | Memantine Hydrochloride | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0527-1943 | Memantine Hydrochloride | Memantine Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-1943 | Memantine Hydrochloride | Memantine Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-1943 | Memantine Hydrochloride | Memantine Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-1943 | Memantine Hydrochloride | Memantine Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-1943 | Memantine Hydrochloride | Memantine Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 62135-943 | Memantine Hydrochloride | Memantine Hydrochloride | Chartwell RX, LLC | ANDA | Current |